NO772106L - Fremgangsm}te for fremstilling av 1-substituerte derivater av difenyl-2,2-cyklopropan - Google Patents

Fremgangsm}te for fremstilling av 1-substituerte derivater av difenyl-2,2-cyklopropan

Info

Publication number: NO772106L
Authority: NO; Norway
Prior art keywords: cyclopropane; diphenyl; formula; aminomethyl; compound
Prior art date: 1976-06-16

Application number

NO772106A

Other languages

English (en)

Norwegian (no)

Inventor

Jean-Claude Cognacq

Original Assignee

Hexachimie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-06-16

Filing date

1977-06-15

Publication date

1977-12-19

1977-06-15 Application filed by Hexachimie filed Critical Hexachimie

1977-12-19 Publication of NO772106L publication Critical patent/NO772106L/no

Links

238000000034 method Methods 0.000 title claims description 11
238000002360 preparation method Methods 0.000 title claims description 10
150000001875 compounds Chemical class 0.000 claims description 11
239000002253 acid Substances 0.000 claims description 8
-1 piperidino, morpholino, piperazino Chemical group 0.000 claims description 6
125000000217 alkyl group Chemical group 0.000 claims description 5
150000003839 salts Chemical class 0.000 claims description 5
239000001257 hydrogen Substances 0.000 claims description 4
229910052739 hydrogen Inorganic materials 0.000 claims description 4
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 4
150000001412 amines Chemical class 0.000 claims description 3
239000000460 chlorine Substances 0.000 claims description 3
229910052757 nitrogen Inorganic materials 0.000 claims description 3
125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
231100000252 nontoxic Toxicity 0.000 claims description 3
230000003000 nontoxic effect Effects 0.000 claims description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
125000004432 carbon atom Chemical group C* 0.000 claims description 2
229910052801 chlorine Inorganic materials 0.000 claims description 2
125000000623 heterocyclic group Chemical group 0.000 claims description 2
239000003960 organic solvent Substances 0.000 claims description 2
DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims 1
125000001309 chloro group Chemical group Cl* 0.000 claims 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 29
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
239000000243 solution Substances 0.000 description 13
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
210000004351 coronary vessel Anatomy 0.000 description 9
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 8
230000008020 evaporation Effects 0.000 description 8
238000001704 evaporation Methods 0.000 description 8
238000003756 stirring Methods 0.000 description 8
VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 5
235000006408 oxalic acid Nutrition 0.000 description 5
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
241000282472 Canis lupus familiaris Species 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
230000002792 vascular Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
PPQDYOBQQWPTIS-UHFFFAOYSA-N 2-(diethylamino)acetamide Chemical compound CCN(CC)CC(N)=O PPQDYOBQQWPTIS-UHFFFAOYSA-N 0.000 description 2
ODMYVDTWPFFABO-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]acetamide Chemical compound NC(=O)CN(CCO)CCO ODMYVDTWPFFABO-UHFFFAOYSA-N 0.000 description 2
BWRNWWSQZROEOA-UHFFFAOYSA-N 2-morpholin-4-ylacetamide Chemical compound NC(=O)CN1CCOCC1 BWRNWWSQZROEOA-UHFFFAOYSA-N 0.000 description 2
JQDXZJYAUSVHDH-UHFFFAOYSA-N 3-chloropropanamide Chemical compound NC(=O)CCCl JQDXZJYAUSVHDH-UHFFFAOYSA-N 0.000 description 2
125000004070 6 membered heterocyclic group Chemical group 0.000 description 2
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
238000013019 agitation Methods 0.000 description 2
210000000709 aorta Anatomy 0.000 description 2
230000035487 diastolic blood pressure Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
210000005240 left ventricle Anatomy 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
235000019341 magnesium sulphate Nutrition 0.000 description 2
239000000203 mixture Substances 0.000 description 2
SOTHHBNFPDRYCM-UHFFFAOYSA-N n-methyl-2-piperazin-1-ylacetamide Chemical compound CNC(=O)CN1CCNCC1 SOTHHBNFPDRYCM-UHFFFAOYSA-N 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
230000035488 systolic blood pressure Effects 0.000 description 2
PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
OEZPDHRXGCLGKB-UHFFFAOYSA-N 2-chloropropanamide Chemical compound CC(Cl)C(N)=O OEZPDHRXGCLGKB-UHFFFAOYSA-N 0.000 description 1
OFILXYRUXDYLLS-UHFFFAOYSA-N 2-piperidin-1-ylacetamide Chemical compound NC(=O)CN1CCCCC1 OFILXYRUXDYLLS-UHFFFAOYSA-N 0.000 description 1
125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
206010002383 Angina Pectoris Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
208000001953 Hypotension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000004872 arterial blood pressure Effects 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
210000000748 cardiovascular system Anatomy 0.000 description 1
210000001715 carotid artery Anatomy 0.000 description 1
RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
229960002327 chloral hydrate Drugs 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
230000001435 haemodynamic effect Effects 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
230000036543 hypotension Effects 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000155 melt Substances 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000033764 rhythmic process Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000000304 vasodilatating effect Effects 0.000 description 1
230000024883 vasodilation Effects 0.000 description 1
210000003462 vein Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO772106A 1976-06-16 1977-06-15 Fremgangsm}te for fremstilling av 1-substituerte derivater av difenyl-2,2-cyklopropan NO772106L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB2489876		1976-06-16

Publications (1)

Publication Number	Publication Date
NO772106L true NO772106L (no)	1977-12-19

Family

ID=10219013

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO772106A NO772106L (no)	1976-06-16	1977-06-15	Fremgangsm}te for fremstilling av 1-substituerte derivater av difenyl-2,2-cyklopropan

Country Status (14)

Country	Link
JP (1)	JPS537654A (fr)
BE (1)	BE855689A (fr)
CH (1)	CH603553A5 (fr)
DD (1)	DD129902A5 (fr)
DE (1)	DE2726993A1 (fr)
DK (1)	DK265277A (fr)
ES (1)	ES459650A1 (fr)
FR (1)	FR2354997A1 (fr)
GR (1)	GR58465B (fr)
NL (1)	NL7706364A (fr)
NO (1)	NO772106L (fr)
PT (1)	PT66589B (fr)
SE (1)	SE7706895L (fr)
ZA (1)	ZA773350B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR014195A1 (es)	1997-12-29	2001-02-07	Ortho Mcneil Pharm Inc	Compuestos de trifenilpropanamida utiles para el tratamiento de procesos inflamatorios, composiciones anti-inflamatorias que los comprenden, ymetodos para prepararlos

1977
- 1977-05-24 PT PT66589A patent/PT66589B/fr unknown
- 1977-05-31 FR FR7716540A patent/FR2354997A1/fr not_active Withdrawn
- 1977-06-02 GR GR53613A patent/GR58465B/el unknown
- 1977-06-03 ZA ZA00773350A patent/ZA773350B/xx unknown
- 1977-06-06 JP JP6721877A patent/JPS537654A/ja active Pending
- 1977-06-08 ES ES459650A patent/ES459650A1/es not_active Expired
- 1977-06-09 NL NL7706364A patent/NL7706364A/xx not_active Application Discontinuation
- 1977-06-13 CH CH722177A patent/CH603553A5/xx not_active IP Right Cessation
- 1977-06-14 DD DD7700199486A patent/DD129902A5/xx unknown
- 1977-06-15 BE BE2055987A patent/BE855689A/fr unknown
- 1977-06-15 SE SE7706895A patent/SE7706895L/xx unknown
- 1977-06-15 NO NO772106A patent/NO772106L/no unknown
- 1977-06-15 DK DK265277A patent/DK265277A/da unknown
- 1977-06-15 DE DE19772726993 patent/DE2726993A1/de active Pending

Also Published As

Publication number	Publication date
FR2354997A1 (fr)	1978-01-13
NL7706364A (nl)	1977-12-20
JPS537654A (en)	1978-01-24
BE855689A (fr)	1977-12-15
PT66589A (fr)	1977-06-01
ES459650A1 (es)	1978-05-01
PT66589B (fr)	1978-10-23
DD129902A5 (de)	1978-02-15
ZA773350B (en)	1978-04-26
SE7706895L (sv)	1977-12-17
CH603553A5 (fr)	1978-08-31
GR58465B (en)	1977-10-12
DK265277A (da)	1977-12-17
DE2726993A1 (de)	1977-12-29

Publication	Publication Date	Title
US3282938A (en)	1966-11-01	3-tertiary aminoloweralkyl-4-lower alkyl or phenyl-7-lower carbalkoxy lower alkyl or carboxy lower alkyl coumarins
DK158980B (da)	1990-08-13	Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK143275B (da)	1981-08-03	Analogifremgangsmaade til fremstilling af 1-(3-dimethylaminopropyl)-phthalanderivater eller syreadditionssalte deraf
RU2036922C1 (ru)	1995-06-09	Производные 1,4-дигидропиридина или их гидрохлориды, обладающие антагонистическими свойствами по отношению к ионам кальция
JPS62167752A (ja)	1987-07-24	フエニルアセトニトリル誘導体その医薬組成物および哺乳動物におけるカルシウムイオンきつ抗作用または抗高圧作用促進方法
SU1333237A3 (ru)	1987-08-23	Способ получени производных пиперидиндиона-2,6 или их солей
US2643255A (en)	1953-06-23	Method of preparing piperazine compounds and a new type of compound produced thereby
NO772106L (no)	1977-12-19	Fremgangsm}te for fremstilling av 1-substituerte derivater av difenyl-2,2-cyklopropan
US3141019A (en)	1964-07-14	Chaohj
KR920005827B1 (ko)	1992-07-20	벤조티아디아제핀 유도체
US4731376A (en)	1988-03-15	2-(-(2,2,5,5-tetramethyl-3-pyrrolin-3-carbonyl))-amino derivatives
DK154083B (da)	1988-10-10	Analogifremgangsmaade til fremstilling af halogenvincamonderivater eller optisk aktive isomere eller syreadditionssalte deraf
DK151028B (da)	1987-10-12	Analogifremgangsmaade til fremstilling af 1,3-tiazolo(4,3-a)isokinoliner eller salte deraf
US3086972A (en)	1963-04-23	Aza-thiaxanthene derivatives
JPH03501389A (ja)	1991-03-28	新規チエニルオキシ‐アルキルアミン誘導体、その製法及びこの化合物を含有する医薬
KR880001715B1 (ko)	1988-09-08	1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법
DK141068B (da)	1980-01-07	Analogifremgangsmaade til fremstilling af indolkinolizinderivater eller salte eller optisk aktive isomer deraf
US4588723A (en)	1986-05-13	Aminoalkyl-imidazothiadiazole-alkenecarboxylic acid amides, intermediates for their preparation and their use in medicaments
HU194213B (en)	1988-01-28	Process for production of 3-alkoxi-2-n-pirrolidin-n-piridil-n-furil /or n-tienil/-methil-prophil amins
DK141529B (da)	1980-04-14	Analogifremgangsmaade til fremstilling af indolderivater eller salte deraf
US3726902A (en)	1973-04-10	Furfuryl amino-coumarins
JPS5944312B2 (ja)	1984-10-29	インダゾ−ル誘導体の製法
US2731467A (en)	1956-01-17	Esters of heterocyclic acids and 1,2,3,4-tetrahydroisoquinoline-2-alkanols
US3772280A (en)	1973-11-13	Thiomorpholine-coumarin derivatives
JPS6130677B2 (fr)	1986-07-15